Prospective Randomised comparison of Off-pump and on-pump MultIvessel coronary artery bypasS Surgery: analysis of early graft patency by multi-slice computed tomography

ISRCTN ISRCTN58800729
DOI https://doi.org/10.1186/ISRCTN58800729
Secondary identifying numbers N/A
Submission date
03/10/2007
Registration date
19/03/2008
Last edited
31/12/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Miguel Uva
Scientific

Hospital da Cruz Vermelha
Rua Duarte Galvao 54
Lisbon
1549-008
Portugal

Phone +351 21 7714000
Email uvamiguel@hotmail.com

Study information

Study designProspective, randomised, controlled, single blinded, single centre study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleProspective Randomised comparison of Off-pump and on-pump MultIvessel coronary artery bypasS Surgery (PROMISS): analysis of early graft patency by multi-slice computed tomography
Study acronymPROMISS
Study objectivesCoronary artery bypass grafting performed without cardiopulmonary bypass (off-pump coronary artery bypass [OPCAB]) has the same early graft patency as if performed with cardiopulmonary bypass (on-pump coronary artery bypass [ONCAB]) and may have reduced complication rate.
Ethics approval(s)Ethics approval received from the Hospital da Cruz Vemelha Ethics Committee on the 4th April 2005.
Health condition(s) or problem(s) studiedMultivessel coronary artery disease
InterventionPatients undergo coronary artery bypass grafting with internal mammary artery, radial or saphenous vein in the two groups using the same anaesthetic protocol, the same graft anastomotic techniques and the same peri-operative (the only exception is heparin dose) and post operative medical treatment. Coronary artery bypass grafting is performed without cardio-pulmonary bypass (off-pump group) or with the use of cardio-pulmonary bypass (on-pump group).

Duration of treatment: two surgical methods are compared in PROMISS so the duration of treatment is that of the surgical procedures (3 - 5 hours). Patients are followed at 1 month (clinical exam) and 6 months (clinical exam, quality of life and stress test).
Intervention typeOther
Primary outcome measureGraft patency at 4 - 6 weeks evaluated by 16 slice computed tomography.
Secondary outcome measures1. Post-operative adverse events
2. Neurocognitive testing at baseline and 4 - 6 weeks
3. Quality of life at baseline and 6 months
4. Adverse events and stress test at 6 months
Overall study start date19/04/2005
Completion date30/01/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants150
Total final enrolment150
Key inclusion criteria1. Patients between 30 and 90 years
2. Multivessel disease
3. Indication for primary coronary artery bypass graft (CABG) for at least three distal anastomoses according to consensus given by two independent surgeons
Key exclusion criteria1. Patient requiring emergency surgery such as:
1.1. Ventilatory support
1.2. Intravenous inotropic therapy
1.3. Cardiogenic shock
1.4. Catheterism accident
1.5. Q-wave myocardial infarction in evolution
2. Need for associated procedures
3. Renal insufficiency or serum creatinine 1.5 times superior to the upper limit normal values
4. Atrial fibrillation
5. Known allergy to contrast material
6. Dyspnoea at rest or inability to hold breath
7. Women with child bearing potential (for the purpose of this study women which have menopause for less than 12 months will be excluded, with exception for those with surgical menopause)
8. Inability to give inform consent
Date of first enrolment19/04/2005
Date of final enrolment30/01/2008

Locations

Countries of recruitment

  • Portugal

Study participating centre

Hospital da Cruz Vermelha
Lisbon
1549-008
Portugal

Sponsor information

Hospital da Cruz Vermelha (Portugal)
Hospital/treatment centre

Rua Duarte Galvao
Lisbon
1549-008
Portugal

ROR logo "ROR" https://ror.org/0120ae790

Funders

Funder type

Industry

Hospital da Cruz Vermelha (Portugal)

No information available

Merck Sharp & Dohme Lda. (Portugal)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 17/07/2008 31/12/2020 Yes No
Results article results 01/10/2010 31/12/2020 Yes No

Editorial Notes

31/12/2020: The following changes have been made:
1. Publication references added.
2. The final enrolment number has been added from the reference.